Loading clinical trials...

Study of Two Dosages of Roaccutane in Cystic Acne | Clinical Trials | Clareo Health

COMPLETEDPhase 4NCT07228481

Study of Two Dosages of Roaccutane in Cystic Acne

This randomized, single-blind, controlled trial was initiated in 2001 to compare two cumulative isotretinoin doses (120 mg/kg vs 150 mg/kg) in patients with moderate-to-severe nodulo-cystic acne. Part...

Lead sponsor: Premier Specialists, Australia•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

WITHDRAWN

A Pilot Study to Explore the Role of Gut Flora in Acne

NCT04214483 · Acne, Acne Vulgaris, and more

COMPLETEDNA

Effect of Different Diets on Isotretinoin Users to Serum Lipid Levels

NCT06250673 · Acne Cystic, Diet, Healthy

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 23, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment91

Start dateJun 2001

Last updatedDec 23, 2025

Condition

Acne Cystic

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 23, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions